CannBioRx Life Sciences (ATNFW) has had the highest return since January 1, 2025 by a micro-cap US stock, returning 4,287.8%.
| ASSET | % RETURN |
|---|---|
CannBioRx Life Sciences (ATNFW) | 4,287.76% |
FiEE (FIEE) | 1,138.53% |
Asset Entities Inc Class B Common Stock (ASST) | 1,130% |
Global Interactive Technologies (GITS) | 804.56% |
Airnet Technology (ANTE) | 801.49% |
Lixte Biotechnology (LIXTW) | 617.86% |
mF International Limited Ordinary Shares (MFI) | 606.21% |
SRM Entertainment, Inc Common Stock (SRM) | 587.72% |
Dominari (DOMH) | 581.75% |
M3-Brigade Acquisition V Corp Warrant (MBAVW) | 581.34% |
Abits (ABTS) | 489.34% |
Immunoprecise Antibodies (IPA) | 478.05% |
Lizhi (SOGP) | 464.5% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 454.91% |
CleanCore Solutions (ZONE) | 430.14% |
ABVC BioPharma (ABVC) | 379.66% |
Palvella Therapeutics (PVLA) | 366.41% |
Quantum BioPharma (QNTM) | 343.42% |
Kindly (NAKA) | 338.71% |
Arena (AREN) | 327.54% |
Super X AI Technology Limited - Ordinary Shares (SUPX) | 324.79% |
CervoMed (CRVO) | 300.83% |
Gryphon Digital Mining (GRYP) | 286.93% |
VivoPower International (VVPR) | 282.22% |
OneConstruction Group Limited Ordinary Shares (ONEG) | 273.44% |
Micro-cap stocks are treated as having a market cap of <= $300M.
